Skip to main content

Prof. Andrea Ardizzoni

Prof Ardizzoni has received his medical degree and completed postgraduate course in internal medicine and medical oncology at the University of Genoa, Italy. He has been Deputy Head of Medical Oncology and Chairman of the Lung Cancer Program at National Institute for Cancer Research of Genoa until 2003. From 2004 to 2014 he has been Head of Medical Oncology at the University Hospital in Parma, Italy and since July 2014 has been appointed as Head of Medical Oncology at University Hospital S.Orsola-Malpighi in Bologna, Italy and since 2017 is Full Professor of Medical Oncology at the University of Bologna. He has published over 400 papers in international peer-reviewed journals indexed by PubMed. Prof Ardizzoni has served as Secretary and Quality Assurance Chairman of the EORTC Lung Cancer Group. He has been also member of ESMO and IASLC Educational Committees. Prof Ardizzoni has served as principal investigator of several clinical and translational studies, mainly in the area of lung cancer and mesothelioma treatment, at national and international leve,l and has also received a number of academic research grants from Italian Ministry of Health, Italian Drug Agency, AIRC (Italian Association for Cancer Research).

print
PRINT

Featured content

ESMO23: Small-cell lung cancer highlights

SCLC Expert Interview

Dr. Luis Paz-Ares and Andrea Ardizzoni discuss the top small-cell lung cancer abstracts presented at ESMO 2023.

Supported by:
  • F. Hoffmann-La Roche Ltd.